Cost-effectiveness explorer
Move a new treatment around the cost-effectiveness plane, and see what happens when its carbon footprint is priced in.
A new treatment costs more (or less) than current care and produces more (or fewer) QALYs. Is it worth funding? Change the inputs below.
Things to try
- Set extra QALYs to a negative value with negative cost. Which quadrant are you in, and what does the ICER mean there?
- Keep the treatment just cost-effective, then raise the carbon value. When does the decision flip?
- Why do economists often prefer the net monetary benefit to the ICER?